NCT03449433View on ClinicalTrials.gov

A Meal Test Study of LY900014 in Participants With Type 1 Diabetes Mellitus

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

March 15, 2018

Primary Completion Date

August 14, 2018

Study Completion Date

August 14, 2018

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

LY900014

Administered SC

DRUG

Insulin Lispro

Administered SC

DRUG

Insulin Aspart

Administered SC

DRUG

Insulin Aspart

Administered SC

Trial Locations (1)

41460

Profil Institut für Stoffwechselforschung, Neuss

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT03449433 - A Meal Test Study of LY900014 in Participants With Type 1 Diabetes Mellitus | Biotech Hunter | Biotech Hunter